Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Blankenstein, Thomas Prof. Dr. (14) Niendorf, Thoralf Prof. Dr. (5) Walther, Wolfgang Prof. Dr. (1) 1991 (1) 1992 (5) 1993 (11) 1994 (14) (-) 1995 (12) (-) 1996 (9) 1997 (11) 1998 (12) 1999 (7) 2000 (14) 2001 (11) 2002 (5) 2003 (12) 2004 (13) 2005 (17) 2006 (9) 2007 (15) 2008 (17) 2009 (12) 2010 (15) 2011 (14) 2012 (23) 2013 (38) 2014 (22) 2015 (32) 2016 (28) 2017 (28) 2018 (24) 2019 (26) 2020 (24) 2021 (41) 2022 (19) 2023 (29) 2024 (8) AG Müller/Dechend (ECRC) (1) Anchored Signalling (1) Cellular Neurosciences (39) Developmental Biology / Signal Transduction (12) Developmental Neurobiology (6) (-) Experimental Ultrahigh-Field MR (5) Genetics and Genomics of Cardiovascular Diseases (6) Genome Engineering & Disease Models (15) Hypertension-caused End-Organ Damage (1) Hypertension-Mediated End-Organ Damage (1) Integrative Vascular Biology (1) Intracellular Proteolysis (10) Magnetic Resonance (5) Mathematical Cell Physiology (1) Microenvironmental Regulation in Autoimmunity and Cancer (3) Mobile DNA (3) Molecular Biology of Peptide Hormones (16) Molecular Cardiovascular Research (11) Molecular Genetics of Chronic Inflammation and Allergic Disease (2) (-) Molecular Immunology and Gene Therapy (16) Molecular Physiology of Somatic Sensation (7) Myology (5) Nephrology and Inflammatory Vascular Diseases (4) Out-patient Clinic for Pediatric Allergology and Atopic Dermatitis (2) Pancreatic Organoid Research and Disease Modeling (2) Proteomics and Molecular Mechanisms of Neurodegenerative Diseases (4) Synaptic Transmission and Plasticity (7) Systems Biology of Gene Regulatory Elements (3) Transgenics (15) Translational Cardiology and Functional Genomics (1) Translational Oncology of Solid Tumors (92) 21 Results: Active Filter: Experimental Ultrahigh-Field MRMolecular Immunology and Gene Therapy19951996 Sort: Result score Newest to oldest Oldest to newest January 01, 1996 / Rev Physiol Biochem Pharmacol Genetic approaches to cancer immunotherapy T. Blankenstein S. Cayeux Z. Qin January 01, 1996 / Eur J Immunol Attenuation of collagen induced-arthritis in mice by treatment with vector cells engineered to secrete interleukin-13 N. Bessis M.C. Boissie P. Ferrara T. Blankenstein D. Fradelizi C. Fournier January 01, 1995 / Int J Oncol Influence of retrovirally transduced human tumor-necrosis-factor-alpha on the expression of C-myc, k-ras, C-jun, p53, tgf-alpha, and cea in human colon-carcinoma cell-lines W. Uckert W. Walther O. Hummel January 01, 1995 / Blood Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice Z. Qin L.J.H. van Tits W.A. Buurman T. Blankenstein January 01, 1995 / J Immunol IL-10 converts mouse lymphoma cells to a CTL-resistant, nk-sensitive phenotype with low but peptide-inducible MHC class I expression F. Salazar-Onfray M. Petersson L. Franksson M. Matsuda T. Blankenstein K. Karre R. Kiessling January 01, 1995 / Eur J Immunol Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines S. Cayeux C. Beck A. Aicher B. Doerken T. Blankenstein January 01, 1995 / Eur J Cancer European school of oncology position paper - gene therapy for the medical oncologist M. Blaese T. Blankenstein M. Brenner O. Cohenhaguenauer B. Gansbacher B. Sorrentino T. Velu January 01, 1996 / Nature Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein S. Brocke K. Gijbels M. Allegretta I. Ferber C. Piercy T. Blankenstein R. Martin U. Utz N. Karin D. Mitchell T. Veromaa A. Waisman A. Gaur P. Conlon N. Ling P.J. Fairchild D.C. Wraith A. Ogarra C.G. Fathman L. Steinman January 01, 1995 / Hum Gene Ther The thymidine kinase/ganciclovir-mediated "suicide" effect is highly variable in different tumor cells C. Beck S. Cayeux S. Lupton B. Doerken T. Blankenstein January 01, 1995 / Canc Res Tumor growth inhibition mediated by lymphotoxin: evidence of B lymphocyte involvement in the antitumor response Z. Qin T. Blankenstein Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
January 01, 1996 / Rev Physiol Biochem Pharmacol Genetic approaches to cancer immunotherapy T. Blankenstein S. Cayeux Z. Qin
January 01, 1996 / Eur J Immunol Attenuation of collagen induced-arthritis in mice by treatment with vector cells engineered to secrete interleukin-13 N. Bessis M.C. Boissie P. Ferrara T. Blankenstein D. Fradelizi C. Fournier
January 01, 1995 / Int J Oncol Influence of retrovirally transduced human tumor-necrosis-factor-alpha on the expression of C-myc, k-ras, C-jun, p53, tgf-alpha, and cea in human colon-carcinoma cell-lines W. Uckert W. Walther O. Hummel
January 01, 1995 / Blood Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice Z. Qin L.J.H. van Tits W.A. Buurman T. Blankenstein
January 01, 1995 / J Immunol IL-10 converts mouse lymphoma cells to a CTL-resistant, nk-sensitive phenotype with low but peptide-inducible MHC class I expression F. Salazar-Onfray M. Petersson L. Franksson M. Matsuda T. Blankenstein K. Karre R. Kiessling
January 01, 1995 / Eur J Immunol Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines S. Cayeux C. Beck A. Aicher B. Doerken T. Blankenstein
January 01, 1995 / Eur J Cancer European school of oncology position paper - gene therapy for the medical oncologist M. Blaese T. Blankenstein M. Brenner O. Cohenhaguenauer B. Gansbacher B. Sorrentino T. Velu
January 01, 1996 / Nature Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein S. Brocke K. Gijbels M. Allegretta I. Ferber C. Piercy T. Blankenstein R. Martin U. Utz N. Karin D. Mitchell T. Veromaa A. Waisman A. Gaur P. Conlon N. Ling P.J. Fairchild D.C. Wraith A. Ogarra C.G. Fathman L. Steinman
January 01, 1995 / Hum Gene Ther The thymidine kinase/ganciclovir-mediated "suicide" effect is highly variable in different tumor cells C. Beck S. Cayeux S. Lupton B. Doerken T. Blankenstein
January 01, 1995 / Canc Res Tumor growth inhibition mediated by lymphotoxin: evidence of B lymphocyte involvement in the antitumor response Z. Qin T. Blankenstein